CVSA Covista Inc. Common Shares
O Covista Inc. Common Shares Przegląd firmy z Wikipedii
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Czytaj więcej
Covista Inc., previously Adtalem Global Education Inc. and, before that, the DeVry Education Group, is a US corporation based in Chicago, Illinois, that operates for-profit higher education institutions, including American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine, and Walden University.
Before June 2018, the corporation was known as DeVry Education Group Inc. Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017. Adtalem began the process to sell off DeVry University and Keller Graduate School of Management later that year to focus on healthcare professional education. Adtalem subsequently renamed itself Covista in 2026.
History
DeVry Inc. was created in 1987 with the merger of DeVry Institute of Technology (DIT) and the Keller Graduate School of Management. DIT was established in Chicago as the DeForest Training School in 1931 and was acquired by Bell & Howell in 1967. Keller was started by two DIT teachers in 1973; the company acquired DIT from Bell & Howell in 1987. DeVry Inc. went public in 1991, moved to the New York Stock Exchange in 1995, and became known as DeVry Education Group in 2013. The company was previously based in Downers Grove, Illinois.
In 2012, the company moved 150 jobs from its campus in Roscoe Village to a new office in Chicago's West Loop. The company had additional offices in Oak Brook, as of 2013. In 2015, the company opened another office in the West Loop, after the city approved a $1 million subsidy for the company in the form of tax increment financing in 2012.
In November 2013, DeVry Inc. was renamed DeVry Education Group.
Rebranding from DeVry Education Group to Adtalem Global Education
Following a $100 million settlement with the FTC in 2016 regarding deceptive advertising, DeVry Education Group rebranded as Adtalem Global Education in 2017 and began the process to sell off DeVry University and Keller Graduate School of Management later that year. The company stated that the new name signified a renewed focus on professional education in the health care and financial services sectors. Industry analysts characterized the move as an effort to move on from DeVry's legal, financial and reputational challenges.
Inside Higher Ed said, "Even before the new name change, the company has sought to differentiate itself publicly from the rest of the for-profit sector. It has responded to increased regulatory scrutiny -- and negative headlines -- for the sector by announcing self-imposed reforms such as voluntarily limiting the amount of revenue it takes in from federal aid."
The company's headquarters were later relocated from Downers Grove to 500 West Monroe Street in the West Loop Gate. In 2024, Crain's Chicago Business said Adtalem had become "the largest health care educator in the nation during a post-COVID period in which the health care sector has faced severe labor shortages". In November 2024, Adtalem announced plans to expand office capacity by moving to an 84,000-square-foot space in Willis Tower in early 2025. In late 2024, Adtalem partnered with Hippocratic AI to train health care professionals on using artificial intelligence.
Acquisitions and divestitures
Adtalem acquired Becker CPA Review (now known as Becker Professional Education), which prepared students for the Certified Public Accountant exam, in 1996. Adtalem acquired Ross University School of Veterinary Medicine in 2003, Chamberlain University (then Deaconess School of Nursing) in 2005, and American University of the Caribbean in 2011. Adtalem agreed to purchase Walden University for approximately $1.5 billion in September 2020. The agreement required approval by the U.S. Department of Education and the Higher Learning Commission. When the deal closed in August 2021, Adtalem became the largest provider of graduate and undergraduate degrees in nursing.
At the time of the re-branding, approximately half of Adtalem's 225,000 students were based in Brazil and approximately one fifth were studying healthcare. Adtalem went on to divest from the Brazil operations in May 2020.
Adtalem began selling business units unrelated to healthcare education in 2017 and consolidated focus on the industry during 2019–2020, when there was a shortage of health professionals. In 2018, the company sold Carrington College to San Joaquin Valley College, as well as DeVry University to Cogswell Education. In 2019, Kaplan, Inc. acquired Becker's healthcare test preparation assets. Kaplan also agreed to provide Adtalem with U.S. Medical Licensing Examination review programs to Ross University School of Medicine and American University of the Caribbean. In 2022, Colibri Group acquired Becker and OnCourse Learning from Adtalem. Adtalem also sold the Association of Certified Anti-Money Laundering Specialists to the French investment company Wendel. The specific purchase terms were not disclosed, but Adtalem confirmed that its financial services segment, which included ACAMLS, Becker, and OnCourse, sold for $1 billion. Since selling its financial services education business, Adtalem has focused primarily on healthcare education.
Operations
Campuses and enrollment
Adtalem's institutions operated approximately 130 campuses globally in 2018. Twelve of the 90 U.S. campuses were located in Illinois. In 2020, Adtalem's businesses operated 26 campuses in four countries and fifteen U.S. states. Approximately 90,000 students attended schools with a combined 6,100 faculty members. According to Adtalem, 34 percent of the students were Black. The company also claimed to be the largest provider of Master's, doctorate, and nursing degrees for African Americans. As of 2021, approximately 82 percent of the 140,000 students enrolled at Adtalem schools learned via distance education. In 2022, Adtalem operated 27 campuses and offered courses in 209 countries and territories.
Leadership
Stephen Beard, who was previously Adtalem's chief operating officer, became the chief executive officer (CEO) in 2021. He was appointed the chair of the board of directors in November 2024, succeeding Michael W. Malafronte. Beard was included in Time magazine's 2025 "Time100 Health" list of influential people in the healthcare industry.
Chris Begley was the board chair in 2016. Daniel Hamburger and Lisa Wardell have previously held the CEO role. Wardell was appointed in 2016. She was the only Black woman to lead a Fortune 1000 company in 2018, according to Crain's Chicago Business. Wardell was also the board chair in 2019. In 2021, an analysis by the University of Illinois Urbana-Champaign ranked Adtalem in the top five Illinois-based public firms for both gender and racial diversity on the board.
Finances
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students. In 2017, Adtalem lost approximately $4.6 million from the impacts of Hurricane Irma and Hurricane Maria. The company made a profit of $95.6 million in 2019 and lost $85.8 million in 2020, suffering from enrollment declines during the COVID-19 pandemic. In early 2024, Adtalem was targeted by a short seller and the company announced a $300 million repurchase program. In late 2024, Investor's Business Daily said Adtalem saw an average sales growth of fourteen percent over the last three years. For the 2024 fiscal year, Adtalem repurchased 5.446 million shares for approximately $261 million. In May 2025, the repurchase was completed and a new stock buyback program of up to $150 million through May 2028 was launched.
Controversies
Covista, formerly known as DeVry Education Group, has been the subject of numerous investigations and lawsuits alleging that a variety of false or deceptive practices. While the group has generally denied the allegations, several cases led to multi-million dollar settlements.
In December 2016, DeVry Education Group agreed to a $100 million settlement of a lawsuit regarding deceptive advertising filed by the U.S Federal Trade Commission. Under the settlement, the group agreed to pay $49.4 million in cash to students and forgive $50.6 million in loans to students.
Months after the FTC settlement, DeVry Education Group rebranded as Adtalem Global Education in May 2018. Adtalem rebranded as Covista in 2026.
For-profit higher education in the United States has been the subject of hearings by the United States Senate Committee on Health, Education, Labor, and Pensions. Specifically regarding DeVry, the Committee found that over half of the students enrolled at DeVry in 2008-2009 withdrew by mid-2010. As of 2015, DeVry spent more on marketing than on student instruction.
As of 2013, DeVry Inc. was under investigation by the Attorneys General of the states of Illinois and Massachusetts.
In 2014, accumulated student loan debt from DeVry University and Keller, its graduate school, had reached approximately $12.1 billion.
A lawsuit filed against DeVry alleged deceptive recruiting practices in violation of federal law.
In January 2016, The Federal Trade Commission filed a lawsuit against DeVry Education Group alleging false or misleading advertising. A class action lawsuit was also filed against DeVry Group in US District Court, Northern District of California claiming breaches of contract, good faith and fair dealing, violations of the California Unfair Trade Practices Act, the California False Advertising Act and the California Consumer Legal Remedies Act, and negligent misrepresentations. A confidential settlement was reached.
In May 2016, a shareholder class action lawsuit was filed against DeVry Group, in the US District Court, Northern District of Illinois. The plaintiffs claimed that defendants made false or misleading statements regarding DeVry University's graduate employment rate and the earnings of DeVry University graduates relative to the graduates of other universities and colleges. The case was settled in 2019 for $27.5 million.
In December 2017, a former administrator filed a civil lawsuit number with the Los Angeles Superior Court, seeking relief for a number of causes of action including Retaliation and Wrongful Termination in Violation of Public Policy for complaining about an incentive-based compensation program that rewarded campus deans for recruiting and enrolling students.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
CVSA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
CVSA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota |
|---|---|
| 30 listopada 2016 | $0,1800 |
| 1 czerwca 2016 | $0,1800 |
| 2 grudnia 2015 | $0,1800 |
| 3 czerwca 2015 | $0,1800 |
| 3 grudnia 2014 | $0,1800 |
| 4 czerwca 2014 | $0,1700 |
| 4 grudnia 2013 | $0,1700 |
| 5 czerwca 2013 | $0,1700 |
| 28 listopada 2012 | $0,1700 |
| 19 czerwca 2012 | $0,1500 |
| 6 grudnia 2011 | $0,1500 |
| 16 czerwca 2011 | $0,1200 |
| 8 grudnia 2010 | $0,1200 |
| 11 czerwca 2010 | $0,1000 |
| 9 grudnia 2009 | $0,1000 |
| 12 czerwca 2009 | $0,0800 |
| 10 grudnia 2008 | $0,0800 |
| 17 czerwca 2008 | $0,0600 |
| 12 grudnia 2007 | $0,0600 |
| 14 czerwca 2007 | $0,0500 |
CVSA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
- Mocne kupno 4 40,0%
- Kup 5 50,0%
- Trzymaj 1 10,0%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
4 analityków · 2026-08-18Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $2.09 | $1.93 | 0.16% |
| 31 marca 2026 | $1.98 | $1.76 | 0.22% |
| 31 grudnia 2025 | $2.43 | $2.23 | 0.20% |
| 30 września 2025 | $1.75 | $1.61 | 0.14% |
| 30 czerwca 2025 | $1.66 | $1.56 | 0.10% |
| 31 marca 2025 | $1.92 | $1.69 | 0.23% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CVSA | $4.24B | 17.7 | 9.3% | 12.9% | 17.8% | — |
| DUOL | $8.18B | 20.5 | 38.7% | 39.9% | 35.6% | 72.2% |
| LAUR | $4.81B | 17.8 | 8.6% | 16.6% | 26.2% | — |
| GHC | — | 16.5 | 2.5% | 5.9% | 6.5% | — |
| LOPE | $4.56B | 21.6 | 7.1% | 19.5% | 28.3% | — |
| LRN | $3.58B | 12.1 | 4.7% | 13.4% | 21.3% | 37.8% |
| BFAM | $5.64B | 30.2 | 9.2% | 6.6% | 14.1% | 23.8% |
| MH | $2.62B | 72.1 | 0.07% | 1.7% | 4.6% | 80.9% |
| PRDO | $1.83B | 12.1 | 24.2% | 18.9% | 16.3% | — |
| STRA | $1.84B | 14.8 | 4.0% | 10.0% | 7.6% | — |
| UTI | $1.77B | 28.8 | 14.1% | 7.5% | 20.3% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Cost of Revenue | $834M | $771M | $699M | $648M | $660M | · | · | · | |
| SG&A Expense | $731M | $672M | $633M | $586M | $566M | · | · | · | |
| Operating Expenses | $1.57B | $1.45B | $1.37B | $1.28B | $1.31B | · | · | · | |
| Operating Income | $383M | $342M | $217M | $168M | $77M | · | · | · | |
| Interest Expense | $45M | $52M | $64M | $63M | $129M | · | · | · | |
| Interest Income | · | · | · | · | $4M | · | · | · | |
| Other Non-op | $7M | $9M | $11M | $7M | $1M | · | · | · | |
| Pretax Income | $345M | $299M | $164M | $112M | $-51M | · | · | · | |
| Income Tax | $78M | $66M | $26M | $10M | $-16M | · | · | · | |
| Net Income | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| EPS (Basic) | $7.18 | $6.39 | $3.47 | $2.08 | $6.43 | · | · | · | |
| EPS (Diluted) | $7.04 | $6.18 | $3.39 | $2.05 | $6.43 | · | · | · | |
| Shares (Basic) | 35,045,000 | 37,085,000 | 39,413,000 | 44,781,000 | 48,388,000 | · | · | · | |
| Shares (Diluted) | 35,715,000 | 38,334,000 | 40,307,000 | 45,600,000 | 48,388,000 | · | · | · | |
| EBITDA | $383M | $342M | $217M | $168M | $80M | · | · | · |
Bilans 28
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $200M | $219M | $272M | $347M | $275M | $416M | $67M | |
| Short-term Investments | · | · | · | · | · | · | · | $9M | |
| Receivables | $167M | $143M | $124M | $100M | $79M | $90M | $69M | · | |
| Prepaid Expense | $75M | $69M | $70M | $102M | $128M | $167M | $97M | $45M | |
| Current Assets | $652M | $416M | $418M | $480M | $557M | $611M | $681M | $390M | |
| PP&E (Net) | $303M | $256M | $249M | $245M | $290M | $302M | $279M | $282M | |
| PP&E (Gross) | $686M | $598M | $575M | $583M | $666M | $663M | $618M | $605M | |
| Accum. Depreciation | $383M | $342M | $326M | $339M | $376M | $362M | $339M | $323M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $960M | $310M | $687M | |
| Intangibles | $754M | $765M | $777M | $812M | $874M | $924M | $138M | $293M | |
| Other Non-current Assets | $138M | $129M | $103M | $81M | $119M | $118M | $88M | $83M | |
| Total Assets | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Accounts Payable | $125M | $105M | $103M | $82M | $57M | $65M | $39M | $31M | |
| Accrued Liabilities | $94M | $77M | $97M | $106M | $98M | $135M | $97M | $90M | |
| Current Liabilities | $597M | $508M | $488M | $431M | $424M | $497M | $341M | $304M | |
| Capital Leases | $208M | $186M | $168M | $163M | $177M | $156M | $194M | $180M | |
| Deferred Tax | $62M | $32M | $30M | $26M | $26M | $27M | $25M | $25M | |
| Other Non-current Liabilities | $42M | $40M | $39M | $37M | $74M | $58M | $81M | $89M | |
| Total Liabilities | $1.57B | $1.32B | $1.37B | $1.35B | $1.54B | $2.37B | $959M | $1.09B | |
| Long-term Debt | $663M | $553M | $649M | $695M | $839M | $1.61B | $287M | $415M | |
| Total Debt | $663M | $553M | $649M | $695M | $839M | · | · | · | |
| Common Stock | $848.0K | $839.0K | $832.0K | $822.0K | $818.0K | $817.0K | $810.0K | $806.0K | |
| Retained Earnings | $3.03B | $2.78B | $2.54B | $2.40B | $2.31B | $1.96B | $1.97B | $2.03B | |
| Treasury Stock | $2.29B | $2.01B | $1.78B | $1.51B | $1.34B | $1.22B | $1.16B | $1.08B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-634.0K | $-8M | $-159M | |
| Stockholders' Equity | $1.45B | $1.43B | $1.37B | $1.46B | $1.49B | $1.28B | $1.31B | $1.29B | |
| Liabilities + Equity | $3.01B | $2.75B | $2.74B | $2.81B | $3.03B | $3.66B | $2.27B | $2.39B | |
| Shares Outstanding | 34,033,000 | 35,952,000 | 37,681,000 | 82,232,000 | 81,796,000 | 81,705,000 | 81,021,000 | 52,953,000 |
Przepływy pieniężne 16
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $41M | $42M | $26M | $14M | $23M | · | · | · | |
| Deferred Tax | $68M | $18M | $11M | $-5M | $-14M | · | · | · | |
| Amort. of Intangibles | $11M | $11M | $36M | $61M | $97M | · | · | · | |
| Restructuring | $6M | $3M | $2M | $19M | $26M | · | · | · | |
| Operating Cash Flow | $470M | $338M | $296M | $192M | $11M | · | · | · | |
| CapEx | $78M | $50M | $49M | $26M | $31M | · | · | · | |
| Investing Cash Flow | $-84M | $-42M | $-48M | $24M | $-552M | · | · | · | |
| Debt Issued | $1.01B | $10M | $2M | $0 | $850M | · | · | · | |
| Net Debt Issued | $112M | $-100M | $-50M | $-151M | $-230M | · | · | · | |
| Stock Repurchased | $240M | $213M | $262M | $123M | $120M | · | · | · | |
| Net Stock Activity | $-240M | $-213M | $-262M | $-123M | $-120M | · | · | · | |
| Financing Cash Flow | $-180M | $-316M | $-302M | $-289M | $-424M | · | · | · | |
| Net Change in Cash | $207M | $-20M | $-54M | $-73M | $-966M | · | · | · | |
| Taxes Paid | $14M | $33M | $31M | $12M | $94M | · | · | · | |
| Free Cash Flow | $393M | $288M | $247M | $166M | $-21M | · | · | · | |
| Levered FCF | $358M | $247M | $193M | $109M | $-106M | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| Net Margin | 12.9% | 13.3% | 8.6% | 6.4% | 22.9% | · | · | · | |
| Pretax Margin | 17.7% | 16.7% | 10.3% | 7.7% | -3.2% | · | · | · | |
| EBITDA Margin | 19.6% | 19.1% | 13.7% | 11.6% | 5.8% | · | · | · | |
| ROA | 8.7% | 8.6% | 4.9% | 3.3% | 9.7% | · | · | · | |
| ROE | 17.8% | 16.5% | 10.2% | 6.3% | 21.3% | · | · | · | |
| ROIC | 14.1% | 13.4% | 9.0% | 7.1% | 2.3% | · | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | 0.8 | 0.9 | 1.1 | 1.3 | · | · | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 0.9 | 1.0 | · | · | · | |
| Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| LT Debt / Equity | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | · | · | · | |
| Interest Coverage | 8.4 | 6.5 | 3.4 | 2.7 | 0.6 | · | · | · |
Efektywność 2
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.7 | 0.6 | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 12.6 | 13.4 | 14.1 | 16.2 | 16.1 | · | · | · |
Stopy Wzrostu 9
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 9.3% | 12.8% | 9.2% | 5.0% | 53.7% | · | · | · | |
| Revenue CAGR 3Y | 10.4% | 9.0% | 20.8% | 18.8% | · | · | · | · | |
| Revenue CAGR 5Y | 16.8% | 15.6% | · | · | · | · | · | · | |
| EPS YoY | 13.9% | 82.3% | 65.4% | -68.1% | 372.8% | · | · | · | |
| EPS CAGR 3Y | 50.9% | -1.3% | 35.6% | · | · | · | · | · | |
| EPS CAGR 5Y | 38.9% | · | · | · | · | · | · | · | |
| Net Income YoY | 6.1% | 73.3% | 46.5% | -70.0% | 344.1% | · | · | · | |
| Net Income CAGR 3Y | 39.2% | -8.6% | 25.0% | · | · | · | · | · | |
| Net Income CAGR 5Y | 29.1% | · | · | · | · | · | · | · |
Wycena (TTM) 13
| Wskaźnik | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.95B | $1.79B | $1.58B | $1.45B | $1.38B | · | · | · | |
| Net Income TTM | $252M | $237M | $137M | $93M | $311M | · | · | · | |
| Market Cap | $4.24B | $4.57B | $2.57B | $1.45B | $1.63B | · | · | · | |
| Enterprise Value | $4.50B | $4.93B | $3.00B | $1.87B | $2.12B | · | · | · | |
| P/E | 17.7 | 20.6 | 20.1 | 16.8 | 5.6 | · | · | · | |
| P/S | 2.2 | 2.6 | 1.6 | 1.0 | 1.2 | · | · | · | |
| P/B | 2.9 | 3.2 | 1.9 | 1.0 | 1.1 | · | · | · | |
| P / Cash Flow | 9.0 | 13.5 | 8.7 | 7.2 | 155.9 | · | · | · | |
| P / FCF | 10.8 | 15.9 | 10.4 | 8.8 | -78.8 | · | · | · | |
| EV / EBITDA | 11.7 | 14.4 | 13.8 | 11.1 | 26.3 | · | · | · | |
| EV / FCF | 11.5 | 17.1 | 12.2 | 11.3 | -102.6 | · | · | · | |
| EV / Revenue | 2.3 | 2.8 | 1.9 | 1.3 | 1.5 | · | · | · | |
| Earnings Yield | 5.7% | 4.9% | 5.0% | 6.0% | 17.9% | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $501M | $487M | $503M | $462M | $457M | $466M | $448M | $417M | $410M | $413M | $393M | $369M | $365M | $369M | $363M | $354M | |
| Cost of Revenue | $217M | $211M | $205M | $201M | $199M | $200M | $187M | $186M | $183M | $175M | $172M | $169M | $164M | $166M | $159M | $160M | |
| SG&A Expense | $188M | $184M | $183M | $176M | $181M | $175M | $157M | $159M | $155M | $157M | $156M | $166M | $153M | $145M | $142M | $146M | |
| Operating Expenses | $406M | $396M | $392M | $377M | $380M | $376M | $344M | $347M | $341M | $351M | $335M | $341M | $325M | $310M | $317M | $331M | |
| Operating Income | $95M | $91M | $111M | $85M | $77M | $91M | $104M | $70M | $69M | $62M | $59M | $28M | $40M | $59M | $46M | $24M | |
| Interest Expense | $10M | $14M | $11M | $11M | $11M | $13M | $14M | $14M | $15M | $17M | $17M | $16M | $15M | $14M | $16M | $18M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | $3M | $2M | $2M | |
| Other Non-op | $3M | $232.0K | $2M | $2M | $3M | $2M | $2M | $3M | $2M | $3M | $4M | $2M | $4M | $4M | $-1M | $761.0K | |
| Pretax Income | $88M | $78M | $102M | $77M | $69M | $79M | $92M | $58M | $56M | $48M | $45M | $15M | $28M | $49M | $29M | $7M | |
| Income Tax | $16M | $20M | $26M | $16M | $14M | $19M | $21M | $12M | $5M | $11M | $8M | $3M | $4M | $389.0K | $4M | $1M | |
| Net Income | $72M | $42M | $76M | $62M | $54M | $61M | $76M | $46M | $49M | $37M | $40M | $11M | $22M | $46M | $25M | $592.0K | |
| EPS (Basic) | $2.12 | $1.21 | $2.14 | $1.71 | $1.50 | $1.64 | $2.03 | $1.22 | $1.26 | $0.95 | $1.00 | $0.26 | $0.51 | $1.02 | $0.54 | $0.01 | |
| EPS (Diluted) | $2.06 | $1.20 | $2.11 | $1.67 | $1.43 | $1.59 | $1.98 | $1.18 | $1.23 | $0.93 | $0.98 | $0.25 | $0.51 | $1.00 | $0.53 | $0.01 | |
| Shares (Basic) | -71,074,000 | 34,283,000 | 35,725,000 | 36,111,000 | -75,211,000 | 37,140,000 | 37,435,000 | 37,721,000 | -80,571,000 | 38,713,000 | 39,872,000 | 41,399,000 | -91,043,000 | 45,125,000 | 45,425,000 | 45,274,000 | |
| Shares (Diluted) | -72,354,000 | 34,782,000 | 36,230,000 | 37,057,000 | -77,409,000 | 38,233,000 | 38,401,000 | 39,109,000 | -82,300,000 | 39,636,000 | 40,787,000 | 42,184,000 | -92,664,000 | 45,801,000 | 46,121,000 | 46,342,000 | |
| EBITDA | · | $91M | $111M | $85M | · | $91M | $104M | $70M | · | $62M | $59M | $28M | · | $59M | $46M | $23M |
Bilans 27
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $406M | $147M | $56M | $265M | $200M | $219M | $194M | $265M | $219M | $180M | $183M | $262M | · | $315M | $208M | $328M | |
| Receivables | $167M | $173M | $160M | $192M | $143M | $160M | $144M | $169M | $124M | $138M | $131M | $145M | · | $111M | $97M | $109M | |
| Prepaid Expense | $75M | $79M | $81M | $106M | $69M | $66M | $65M | $79M | $70M | $59M | $58M | $61M | · | $103M | $114M | $128M | |
| Current Assets | $652M | $404M | $303M | $567M | $416M | $450M | $407M | $517M | $418M | $388M | $378M | $473M | · | $533M | $423M | $570M | |
| PP&E (Net) | $303M | $277M | $266M | $257M | $256M | $251M | $246M | $245M | $249M | $273M | $260M | $265M | · | $253M | $276M | $282M | |
| PP&E (Gross) | $686M | $649M | $627M | $608M | $598M | $583M | $583M | $574M | $575M | $600M | $605M | $609M | · | $583M | $621M | $646M | |
| Accum. Depreciation | $383M | $372M | $361M | $351M | $342M | $332M | $337M | $329M | $326M | $327M | $345M | $345M | · | $330M | $346M | $364M | |
| Goodwill | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | $961M | · | $961M | $961M | $961M | |
| Intangibles | $754M | $757M | $760M | $763M | $765M | $768M | $771M | $774M | $777M | $784M | $792M | $802M | · | $825M | $839M | $855M | |
| Other Non-current Assets | $138M | $137M | $135M | $129M | $129M | $120M | $113M | $108M | $103M | $68M | $66M | $68M | · | $68M | $117M | $121M | |
| Total Assets | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Accounts Payable | $125M | $97M | $103M | $105M | $105M | $99M | $67M | $91M | $103M | $92M | $88M | $77M | · | $73M | $71M | $64M | |
| Accrued Liabilities | $94M | $93M | $72M | $63M | $77M | $86M | $62M | $87M | $97M | $114M | $98M | $89M | · | $87M | $94M | $94M | |
| Current Liabilities | $597M | $580M | $443M | $577M | $508M | $541M | $385M | $551M | $488M | $509M | $399M | $496M | · | $438M | $371M | $491M | |
| Capital Leases | $208M | $202M | $191M | $188M | $186M | $193M | $182M | $162M | $168M | $160M | $169M | $161M | · | $164M | $166M | $165M | |
| Deferred Tax | $62M | $59M | $57M | $53M | $32M | $34M | $32M | $30M | $30M | $29M | $27M | $26M | · | $27M | $27M | $26M | |
| Other Non-current Liabilities | $42M | $37M | $41M | $38M | $40M | $37M | $35M | $35M | $39M | $48M | $41M | $37M | · | $33M | $62M | $63M | |
| Total Liabilities | $1.57B | $1.37B | $1.24B | $1.41B | $1.32B | $1.36B | $1.28B | $1.43B | $1.37B | $1.39B | $1.33B | $1.42B | · | $1.36B | $1.32B | $1.49B | |
| Long-term Debt | $663M | $499M | $504M | $553M | $553M | $552M | $650M | $649M | $649M | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Total Debt | · | $499M | $504M | $553M | · | $552M | $650M | $649M | · | $648M | $696M | $696M | · | $694M | $694M | $742M | |
| Common Stock | $848.0K | $847.0K | $847.0K | $847.0K | $839.0K | $839.0K | $839.0K | $838.0K | $832.0K | $831.0K | $831.0K | $826.0K | · | $822.0K | $822.0K | $821.0K | |
| Retained Earnings | $3.03B | $2.96B | $2.92B | $2.84B | $2.78B | $2.72B | $2.66B | $2.59B | $2.54B | $2.49B | $2.45B | $2.41B | · | $2.38B | $2.35B | $2.33B | |
| Treasury Stock | $2.29B | $2.29B | $2.22B | $2.05B | $2.01B | $1.94B | $1.87B | $1.83B | $1.78B | $1.77B | $1.68B | $1.61B | · | $1.43B | $1.39B | $1.34B | |
| AOCI | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | |
| Stockholders' Equity | $1.45B | $1.36B | $1.38B | $1.46B | $1.43B | $1.43B | $1.44B | $1.39B | $1.37B | $1.32B | $1.37B | $1.38B | $1.46B | $1.51B | $1.52B | $1.51B | |
| Liabilities + Equity | $3.01B | $2.74B | $2.61B | $2.87B | $2.75B | $2.79B | $2.72B | $2.82B | $2.74B | $2.72B | $2.70B | $2.79B | · | $2.87B | $2.84B | $3.00B | |
| Shares Outstanding | 34,033,000 | 34,023,000 | 34,654,000 | 36,324,000 | 35,952,000 | 36,512,000 | 37,289,000 | 37,716,000 | 37,681,000 | 37,765,000 | 39,526,000 | 40,401,000 | 82,232,000 | 44,232,000 | 45,443,000 | 45,396,000 |
Przepływy pieniężne 14
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $10M | $10M | $13M | $8M | $10M | $10M | $11M | $9M | $7M | $6M | $6M | $7M | $3M | $3M | $2M | $6M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $7M | $8M | $9M | $11M | $12M | $14M | $16M | $19M | |
| Restructuring | $1M | $863.0K | $4M | $310.0K | $388.0K | $510.0K | $322.0K | $2M | $653.0K | $473.0K | $68.0K | $676.0K | $1M | $1M | $1M | $15M | |
| Operating Cash Flow | $124M | $186M | $30M | $131M | $60M | $208M | $-19M | $89M | $60M | $143M | $-18M | $95M | $42M | $108M | $-50M | $91M | |
| CapEx | $27M | $20M | $15M | $16M | $19M | $10M | $11M | $10M | $17M | $2M | $5M | $10M | $7M | $9M | $4M | $5M | |
| Investing Cash Flow | $-28M | $-20M | $-20M | $-16M | $-12M | $-10M | $-11M | $-10M | $-16M | $-2M | $-5M | $-10M | $-7M | $44M | $-7M | $-6M | |
| Debt Issued | $163M | $617M | · | · | $0 | $0 | $0 | $10M | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | $0 | · | · | · | $0 | · | · | · | $-101M | |
| Stock Repurchased | $0 | $68M | $165M | $8M | $67M | $72M | $41M | $33M | $12M | $90M | $70M | $90M | $78M | · | · | $0 | |
| Net Stock Activity | · | · | · | $-8M | · | · | · | $-33M | · | · | · | $-90M | · | · | · | · | |
| Financing Cash Flow | $163M | $-76M | $-218M | $-50M | $-68M | $-172M | $-42M | $-34M | $-11M | $-140M | $-56M | $-95M | $-78M | $-44M | $-63M | $-103M | |
| Net Change in Cash | $259M | $90M | $-208M | $65M | $-20M | $26M | $-71M | $46M | $34M | $1M | $-78M | $-11M | $-42M | $107M | $-120M | $-18M | |
| Free Cash Flow | · | · | · | $115M | · | · | · | $79M | · | · | · | $85M | · | · | · | $86M | |
| Levered FCF | · | · | · | $106M | · | · | · | $67M | · | · | · | $72M | · | · | · | $71M |
Rentowność 7
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| Net Margin | · | 8.6% | 15.2% | 13.4% | · | 13.1% | 16.9% | 11.1% | · | 8.9% | 10.1% | 2.9% | · | 12.4% | 6.7% | 0.62% | |
| Pretax Margin | · | 16.0% | 20.2% | 16.6% | · | 17.0% | 20.6% | 14.0% | · | 11.6% | 11.6% | 4.0% | · | 13.3% | 7.7% | 1.9% | |
| EBITDA Margin | · | 18.8% | 22.1% | 18.5% | · | 19.4% | 23.2% | 16.8% | · | 15.0% | 14.9% | 7.6% | · | 16.1% | 12.7% | 6.5% | |
| ROA | · | 1.5% | 2.9% | 2.2% | · | 2.2% | 2.8% | 1.7% | · | 1.3% | 1.4% | 0.37% | · | 1.4% | 0.74% | 0.06% | |
| ROE | · | 3.0% | 5.4% | 4.3% | · | 4.4% | 5.4% | 3.3% | · | 2.6% | 2.8% | 0.74% | · | 3.1% | 1.7% | 0.16% | |
| ROIC | · | 3.6% | 4.4% | 3.4% | · | 3.5% | 3.8% | 2.7% | · | 2.4% | 2.4% | 1.1% | · | 2.7% | 1.8% | 0.87% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.7 | 0.7 | 1.0 | · | 0.8 | 1.1 | 0.9 | · | 0.8 | 0.9 | 1.0 | · | 1.2 | 1.1 | 1.2 | |
| Quick Ratio | · | 0.6 | 0.5 | 0.8 | · | 0.7 | 0.9 | 0.8 | · | 0.6 | 0.8 | 0.8 | · | 1.0 | 0.8 | 0.9 | |
| Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| LT Debt / Equity | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | |
| Interest Coverage | · | 6.7 | 10.2 | 7.7 | · | 6.9 | 7.5 | 4.8 | · | 3.7 | 3.5 | 1.8 | · | 4.1 | 3.0 | 1.3 |
Efektywność 2
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 2.9 | 3.3 | 2.6 | · | 3.1 | 3.3 | 2.7 | · | 3.3 | 3.4 | 2.9 | · | 3.6 | 3.9 | 2.6 |
Wycena (TTM) 13
| Wskaźnik | Trend | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $1.92B | $1.88B | $1.79B | · | $1.74B | $1.67B | $1.59B | · | $1.54B | $1.49B | $1.46B | · | $1.45B | $1.44B | $1.45B | |
| Net Income TTM | · | $241M | $275M | $245M | · | $220M | $199M | $134M | · | $133M | $121M | $82M | · | $79M | $381M | $374M | |
| Market Cap | · | $3.92B | $3.59B | $5.61B | · | $3.67B | $3.39B | $2.85B | · | $1.94B | $2.33B | $1.73B | · | $1.71B | $1.61B | $1.65B | |
| Enterprise Value | · | $4.27B | $4.03B | $5.90B | · | $4.01B | $3.84B | $3.23B | · | $2.41B | $2.84B | $2.16B | · | $2.09B | $2.10B | $2.07B | |
| P/E | · | 17.5 | 14.1 | 24.1 | · | 17.7 | 17.9 | 22.6 | · | 16.3 | 21.4 | 23.9 | · | 22.5 | 4.6 | 4.8 | |
| P/S | · | 2.0 | 1.9 | 3.1 | · | 2.1 | 2.0 | 1.8 | · | 1.3 | 1.6 | 1.2 | · | 1.2 | 1.1 | 1.1 | |
| P/B | · | 2.9 | 2.6 | 3.8 | · | 2.6 | 2.4 | 2.0 | · | 1.5 | 1.7 | 1.3 | · | 1.1 | 1.1 | 1.1 | |
| P / Cash Flow | · | · | · | 43.0 | · | · | · | 31.9 | · | · | · | 17.4 | · | · | · | 18.1 | |
| P / FCF | · | · | · | 49.0 | · | · | · | 36.1 | · | · | · | 20.5 | · | · | · | 19.3 | |
| EV / EBITDA | · | 46.8 | 36.3 | 69.0 | · | 44.3 | 37.0 | 46.0 | · | 39.0 | 48.5 | 76.8 | · | 35.1 | 45.6 | 89.6 | |
| EV / FCF | · | · | · | 51.5 | · | · | · | 41.0 | · | · | · | 25.6 | · | · | · | 24.1 | |
| EV / Revenue | · | 2.2 | 2.1 | 3.3 | · | 2.3 | 2.3 | 2.0 | · | 1.6 | 1.9 | 1.5 | · | 1.4 | 1.5 | 1.4 | |
| Earnings Yield | · | 5.7% | 7.1% | 4.2% | · | 5.6% | 5.6% | 4.4% | · | 6.2% | 4.7% | 4.2% | · | 4.5% | 21.9% | 20.8% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Przychody | $1.95B | $1.79B | $1.58B | $1.45B | — |
| Marża Operacyjna % | 19.6% | 19.1% | 13.7% | 11.6% | — |
| Zysk netto | $252M | $237M | $137M | $93M | — |
| Rozwodniony EPS | $7.04 | $6.18 | $3.39 | $2.05 | — |
Bilans
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.5 | 0.4 | 0.5 | 0.5 | — |
| Wskaźnik bieżący | 1.1 | 0.8 | 0.9 | 1.1 | — |
| Wskaźnik Szybkości | 1.0 | 0.7 | 0.7 | 0.9 | — |
Przepływy pieniężne
| 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $393M | $288M | $247M | $166M | — |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 402 emitenci · $3.0B łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 61 (+15 vs poprzedni kw.) | 30 (-23 vs poprzedni kw.) | 137 (+3 vs poprzedni kw.) | 121 (-7 vs poprzedni kw.) | +4.5M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $418 746 711 | 4 047 035 | 14,07% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $297 558 184 | 2 386 958 | 10,00% | Akcje |
| FMR LLC | $280 021 015 | 2 246 278 | 9,41% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $208 992 241 | 1 676 499 | 7,02% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $183 742 358 | 1 473 948 | 6,17% | Akcje |
| STATE STREET CORP | $173 212 203 | 1 389 477 | 5,82% | Akcje |
| Capital World Investors | $132 593 736 | 1 063 643 | 4,46% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $95 719 361 | 767 678 | 3,22% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $87 910 731 | 705 204 | 2,95% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $78 581 301 | 630 365 | 2,64% | Akcje |
| Alyeska Investment Group, L.P. | $68 807 458 | 551 961 | 2,31% | Akcje |
| Fisher Asset Management, LLC | $63 050 035 | 505 776 | 2,12% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60 245 186 | 483 276 | 2,02% | Akcje |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | $44 010 839 | 353 047 | 1,48% | Akcje |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $37 728 848 | 302 654 | 1,27% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $32 342 164 | 259 443 | 1,09% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $30 437 360 | 244 163 | 1,02% | Akcje |
| PRINCIPAL FINANCIAL GROUP INC | $26 065 659 | 209 094 | 0,88% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $23 386 341 | 187 601 | 0,79% | Akcje |
| SG Capital Management LLC | $22 238 845 | 178 396 | 0,75% | Akcje |
| TWO SIGMA ADVISERS, LP | $19 876 587 | 192 100 | 0,67% | Akcje |
| ALGERT GLOBAL LLC | $19 323 048 | 155 006 | 0,65% | Akcje |
| MORGAN STANLEY | $18 731 418 | 150 260 | 0,63% | Akcje |
| Public Sector Pension Investment Board | $17 393 810 | 139 530 | 0,58% | Akcje |
| Corient Private Wealth LP | $16 950 396 | 135 973 | 0,57% | Akcje |
| WESTPORT ASSET MANAGEMENT INC | $15 677 117 | 125 759 | 0,53% | Akcje |
| Bank of New York Mellon Corp | $15 262 248 | 122 431 | 0,51% | Akcje |
| PRUDENTIAL FINANCIAL INC | $14 091 816 | 113 042 | 0,47% | Akcje |
| MACKENZIE FINANCIAL CORP | $13 510 152 | 108 376 | 0,45% | Akcje |
| Qube Research & Technologies Ltd | $12 647 380 | 101 455 | 0,43% | Akcje |
| BANK OF AMERICA CORP /DE/ | $12 502 650 | 100 294 | 0,42% | Akcje |
| RHUMBLINE ADVISERS | $10 647 181 | 85 410 | 0,36% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $9 671 247 | 77 581 | 0,33% | Akcje |
| Foresight Group Ltd Liability Partnership | $9 636 366 | 77 264 | 0,32% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $9 436 388 | 75 697 | 0,32% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $8 879 782 | 77 048 | 0,30% | Akcje |
| BlackRock, Inc. | $8 832 036 | 70 849 | 0,30% | Akcje |
| LAZARD ASSET MANAGEMENT LLC | $8 696 157 | 69 759 | 0,29% | Akcje |
| Swiss National Bank | $8 638 938 | 69 300 | 0,29% | Akcje |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $8 557 000 | 68 639 | 0,29% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $8 419 536 | 67 540 | 0,28% | Akcje |
| Hillsdale Investment Management Inc. | $8 077 968 | 64 800 | 0,27% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $8 030 847 | 64 422 | 0,27% | Akcje |
| RENAISSANCE GROUP LLC | $7 608 748 | 61 036 | 0,26% | Akcje |
| AMERIPRISE FINANCIAL INC | $7 563 622 | 60 674 | 0,25% | Akcje |
| GOLDMAN SACHS GROUP INC | $7 528 716 | 60 394 | 0,25% | Akcje |
| Allianz Asset Management GmbH | $7 053 013 | 56 578 | 0,24% | Akcje |
| LONESTAR CAPITAL MANAGEMENT LLC | $6 856 300 | 55 000 | 0,23% | Akcje |
| Legal & General Group Plc | $6 503 387 | 52 169 | 0,22% | Akcje |
| Phocas Financial Corp. | $6 345 443 | 50 902 | 0,21% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $6 335 869 | 54 975 | 0,21% | Akcje |
| FIRST TRUST ADVISORS LP | $6 152 968 | 49 358 | 0,21% | Akcje |
| ExodusPoint Capital Management, LP | $5 906 141 | 47 378 | 0,20% | Akcje |
| KESTREL INVESTMENT MANAGEMENT CORP | $5 896 418 | 47 300 | 0,20% | Akcje |
| LEUTHOLD GROUP, LLC | $5 622 914 | 45 106 | 0,19% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $5 482 297 | 43 978 | 0,18% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $5 313 757 | 42 626 | 0,18% | Akcje |
| LGT Fund Management Co Ltd. | $4 992 633 | 40 050 | 0,17% | Akcje |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 840 500 | 42 000 | 0,16% | Akcje |
| Trexquant Investment LP | $4 814 120 | 38 618 | 0,16% | Akcje |
| FARLEY CAPITAL L.P. | $4 644 333 | 37 256 | 0,16% | Akcje |
| SEI INVESTMENTS CO | $4 541 490 | 36 431 | 0,15% | Akcje |
| CHURCHILL MANAGEMENT Corp | $4 474 806 | 35 171 | 0,15% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $4 270 726 | 34 259 | 0,14% | Akcje |
| VANGUARD ASSET MANAGEMENT, Ltd | $3 909 088 | 31 358 | 0,13% | Akcje |
| HSBC HOLDINGS PLC | $3 726 330 | 29 614 | 0,13% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $3 568 268 | 28 624 | 0,12% | Akcje |
| Smith Group Asset Management, LLC | $3 304 113 | 26 505 | 0,11% | Akcje |
| OP Asset Management Ltd | $3 295 387 | 26 435 | 0,11% | Akcje |
| Horizon Investments, LLC | $3 257 730 | 21 000 | 0,11% | Akcje |
| Atom Investors LP | $3 165 242 | 25 391 | 0,11% | Akcje |
| FORMULA GROWTH LTD | $3 140 933 | 25 196 | 0,11% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $3 064 891 | 24 586 | 0,10% | Akcje |
| BARCLAYS PLC | $2 926 019 | 23 472 | 0,10% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $2 840 627 | 22 787 | 0,10% | Akcje |
| NewEdge Wealth, LLC | $2 790 514 | 22 385 | 0,09% | Akcje |
| Elo Mutual Pension Insurance Co | $2 724 943 | 21 859 | 0,09% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $2 717 588 | 21 800 | 0,09% | Akcje |
| NEW YORK STATE COMMON RETIREMENT FUND | $2 695 523 | 21 623 | 0,09% | Akcje |
| MetLife Investment Management, LLC | $2 499 807 | 20 053 | 0,08% | Akcje |
| Global Alpha Capital Management Ltd. | $2 430 995 | 19 501 | 0,08% | Akcje |
| FIFTH THIRD BANCORP | $2 403 502 | 19 280 | 0,08% | Akcje |
| ROYCE & ASSOCIATES LP | $2 376 768 | 19 066 | 0,08% | Akcje |
| Boston Partners | $2 293 116 | 18 393 | 0,08% | Akcje |
| Quantinno Capital Management LP | $2 288 134 | 18 355 | 0,08% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $2 256 097 | 18 098 | 0,08% | Akcje |
| LGT CAPITAL PARTNERS LTD. | $2 206 482 | 17 700 | 0,07% | Akcje |
| IEQ CAPITAL, LLC | $2 199 751 | 17 646 | 0,07% | Akcje |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2 141 829 | 20 700 | 0,07% | Akcje |
| Bridgewater Associates, LP | $2 138 044 | 17 151 | 0,07% | Akcje |
| CITIGROUP INC | $2 106 879 | 16 901 | 0,07% | Akcje |
| CITADEL ADVISORS LLC | $2 106 754 | 16 900 | 0,07% | Opcja kupna |
| Banque Cantonale Vaudoise | $2 082 000 | 16 700 | 0,07% | Akcje |
| Mariner, LLC | $2 075 942 | 16 653 | 0,07% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2 064 120 | 16 558 | 0,07% | Akcje |
| Illinois Municipal Retirement Fund | $2 054 147 | 16 478 | 0,07% | Akcje |
| Gotham Asset Management, LLC | $2 014 256 | 16 158 | 0,07% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1 982 094 | 15 900 | 0,07% | Opcja kupna |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1 977 731 | 15 865 | 0,07% | Akcje |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1 902 312 | 15 260 | 0,06% | Akcje |
Insiderzy spółki 111 insiderów · 46 dyrektorzy generalni · 24 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Hamburger | President and CEO | 31 sierpnia 2015 S | 142 136 | 0 | 0 | $0 |
| Michael O Randolfi | SVP, Chief Financial Officer | 28 sierpnia 2020 F | 84 391 | 0 | 0 | $0 |
| Timothy J Wiggins | SVP & Chief Financial Officer | 25 lutego 2016 S | 44 939 | 0 | 0 | $0 |
| Richard Gunst | Chief Financial Officer | 1 lutego 2012 M | 9 356 | 0 | 0 | $0 |
| Amelia Manning | President, Chamberlain Univ. | 15 lipca 2026 A | 4 317 | 0 | 0 | $0 |
| Karen Sue Cox | President, Chamberlain Univ. | 8 maja 2026 S | 31 596 | 0 | 1 | $-249 000 |
| Scott Liles | President, Medical and Vet | 15 kwietnia 2026 F | 13 103 | 0 | 0 | $0 |
| Evan Trent | President, Adtalem Elevate | 13 listopada 2025 F | 24 134 | 0 | 0 | $0 |
| Thiago Aguiar Sayao | Group President, Business &Law | 28 lutego 2020 S | 1 830 | 0 | 0 | $0 |
| Carlos Filgueiras | Group President, Tech/Business | 13 lutego 2019 S | 11 775 | 0 | 0 | $0 |
| Donna M Loraine | President, Carrington Colleges | 6 listopada 2018 M | 6 701 | 0 | 0 | $0 |
| Susan Groenwald | President, Chamberlain | 9 lutego 2018 M | 34 402 | 0 | 0 | $0 |
| John P Roselli | President, Becker Professional | 1 września 2017 S | 13 730 | 0 | 0 | $0 |
| Eric P. Dirst | President, ATGE Shared Ops | 31 sierpnia 2017 S | 14 800 | 0 | 0 | $0 |
| Robert A Paul | President, DeVry University | 25 sierpnia 2017 M | 28 426 | 0 | 0 | $0 |
| Steven Riehs | President, Med, Prof & Online | 2 września 2016 M | 28 062 | 0 | 0 | $0 |
| Jeffrey Richard Akens | President, Carrington College | 29 sierpnia 2015 F | 6 752 | 0 | 0 | $0 |
| Christopher Caywood | President, Online Services | 1 marca 2013 F | 7 378 | 0 | 0 | $0 |
| Andrew A Jeon | President, DeVry Medical Int'l | 2 listopada 2012 F | 5 655 | 0 | 0 | $0 |
| William B. Hughson | President, Medical & | 29 sierpnia 2012 A | 2 143 | 0 | 0 | $0 |
| Manjunath Gangadharan | VP, Chief Accounting Officer | 18 maja 2026 F | 5 271 | 0 | 1 | $-128 072 |
| Michael Betz | Pres. Walden University & CDO | 13 listopada 2025 F | 33 286 | 0 | 0 | $0 |
| Maurice Herrera | SVP - Chief Marketing Officer | 13 listopada 2025 F | 20 584 | 0 | 0 | $0 |
| Megan Noel | Chief Corp. Affairs Officer | 12 listopada 2025 A | 2 226 | 0 | 0 | $0 |
| Sara Hill | CHRO | 12 listopada 2025 A | 10 276 | 0 | 0 | $0 |
| Blake Simpson | SVP, Chief Comms & CA Officer | 5 grudnia 2024 F | 8 795 | 0 | 0 | $0 |
| Steven Tom | SVP Chief Customer Officer | 13 listopada 2024 A | 13 255 | 0 | 0 | $0 |
| Cheryl James | SVP, CHRO | 28 lutego 2024 F | 17 485 | 0 | 0 | $0 |
| John W Danaher MD | Pres. - Adtalem Med & Vet | 25 sierpnia 2023 F | 38 718 | 0 | 0 | $0 |
| James Raymond Bartholomew | SVP - Chamberlain University | 26 sierpnia 2022 F | 6 418 | 0 | 0 | $0 |
| Holland Katherine Alice Boden | Group Pres, Adtalem Health | 30 sierpnia 2021 F | 32 148 | 0 | 0 | $0 |
| Fernando Lau | SVP, Chief Marketing Officer | 28 sierpnia 2021 F | 19 253 | 0 | 0 | $0 |
| Christopher C Nash | SVP, Chief Information Officer | 28 sierpnia 2021 F | 25 741 | 0 | 0 | $0 |
| Donna Jennings | SVP, Human Resources | 28 sierpnia 2021 F | 30 898 | 0 | 0 | $0 |
| Chaka M Patterson | SVP and General Counsel | 28 sierpnia 2020 F | 5 202 | 0 | 0 | $0 |
| Mehul R Patel | Group Pres, Financial Services | 7 listopada 2019 F | 11 258 | 0 | 0 | $0 |
| Kathleen Carroll | Vice President, Controller | 28 sierpnia 2019 A | 5 497 | 0 | 0 | $0 |
| Lisa M Sodeika | SVP, Corporate Affairs | 28 sierpnia 2019 A | 24 151 | 0 | 0 | $0 |
| Patrick J Unzicker | Principal Financial Officer | 27 sierpnia 2019 F | 36 360 | 0 | 0 | $0 |
| Catherine C. Anderson | SVP, Strategy & Innovation | 26 sierpnia 2019 F | 6 025 | 0 | 0 | $0 |
| Gena L Ashe | SVP, CLO and Secretary | 23 sierpnia 2017 A | 4 420 | 0 | 0 | $0 |
| Gregory S Davis | SVP and General Counsel | 1 września 2016 S | 22 433 | 0 | 0 | $0 |
| Adriano Allegrini | VP, Strategy and Bus. Develop. | 29 sierpnia 2015 F | 7 004 | 0 | 0 | $0 |
| Sharon Thomas Parrott | SVP, Gov. & Regulatory Affairs | 5 listopada 2014 A | 5 610 | 0 | 0 | $0 |
| David J Pauldine | Executive Vice President & | 25 kwietnia 2014 M | 30 242 | 0 | 0 | $0 |
| Thomas C Shepherd | Executive Vice President and | 27 maja 2011 M | 0 | 0 | 0 | $0 |
| Michael W Malafronte | Dyrektor | 11 marca 2026 P | 25 395 | 5 | 0 | $3 844 716 |
| William V Krehbiel | Dyrektor | 13 listopada 2025 F | 16 303 | 0 | 0 | $0 |
| Betty M. Vandenbosch | Dyrektor | 13 listopada 2025 F | 2 584 | 0 | 0 | $0 |
| Kenneth J Phelan | Dyrektor | 13 listopada 2025 F | 19 836 | 1 | 0 | $49 931 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| International Value Advisers, LLC, Charles de Vaulx ×18 zgłoszenia | 7 sierpnia 2020 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 79 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| PSCD · Invesco Exchange-Traded Fund Trust … | 1,82% | 3 165 SH | 8 sierpnia 2026 | Dziennie |
| PSL · Invesco Exchange-Traded Fund Trust | 1,76% | 10 579 SH | 8 sierpnia 2026 | Dziennie |
| MYLD · Cambria ETF Trust | 0,94% | 2 418 NS | 30 kwietnia 2026 | N-PORT |
| XSHQ · Invesco Exchange-Traded Fund Trust … | 0,91% | 20 685 SH | 8 sierpnia 2026 | Dziennie |
| RZG · Invesco Exchange-Traded Fund Trust | 0,88% | 8 705 SH | 8 sierpnia 2026 | Dziennie |
| CGMM · Capital Group Equity ETF Trust I | 0,80% | 190 016 NS | 31 maja 2026 | N-PORT |
| VUSE · ETF Series Solutions | 0,53% | 31 159 NS | 31 maja 2026 | N-PORT |
| IJT · iShares Trust | 0,47% | 316 256 SH | 8 sierpnia 2026 | Dziennie |
| CAFG · Pacer Funds Trust | 0,47% | 919 NS | 30 kwietnia 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,46% | 40 509 SH | 8 sierpnia 2026 | Dziennie |
| CALF · Pacer Funds Trust | 0,46% | 136 827 NS | 30 kwietnia 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,33% | 29 825 NS | 30 kwietnia 2026 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,27% | 4 982 SH | 8 sierpnia 2026 | Dziennie |
| XJR · iShares Trust | 0,26% | 4 021 SH | 8 sierpnia 2026 | Dziennie |
| IWO · iShares Trust | 0,26% | 312 826 SH | 8 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,26% | 52 359 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,25% | 36 861 SH | 8 sierpnia 2026 | Dziennie |
| IJR · iShares Trust | 0,23% | 2 075 461 SH | 8 sierpnia 2026 | Dziennie |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,23% | 119 030 SH | 8 sierpnia 2026 | Dziennie |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 10 711 NS | 30 kwietnia 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,21% | 4 228 SH | 8 sierpnia 2026 | Dziennie |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,21% | 13 071 NS | 30 kwietnia 2026 | N-PORT |
| SMDX · Tidal Trust III | 0,20% | 2 228 NS | 30 kwietnia 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,20% | 46 807 NS | 31 maja 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,18% | 1 290 NS | 30 kwietnia 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,18% | 217 961 NS | 30 kwietnia 2026 | N-PORT |
| SAA · ProShares Trust | 0,18% | 412 NS | 31 maja 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,14% | 29 761 NS | 30 kwietnia 2026 | N-PORT |
| GMOV · GMO ETF Trust | 0,14% | 1 078 NS | 31 maja 2026 | N-PORT |
| IWM · iShares Trust | 0,13% | 875 500 SH | 8 sierpnia 2026 | Dziennie |
| ISCG · iShares Trust | 0,13% | 10 563 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,13% | 198 216 SH | 8 sierpnia 2026 | Dziennie |
| FNDA · SCHWAB STRATEGIC TRUST | 0,13% | 98 138 NS | 31 maja 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,13% | 19 006 SH | 8 sierpnia 2026 | Dziennie |
| SMLF · iShares Trust | 0,12% | 41 596 SH | 8 sierpnia 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,12% | 4 599 SH | 8 sierpnia 2026 | Dziennie |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 15 066 SH | 8 sierpnia 2026 | Dziennie |
| VCR · VANGUARD WORLD FUND | 0,12% | 67 714 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,12% | 14 797 NS | 30 kwietnia 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,11% | 12 017 NS | 30 kwietnia 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,11% | 9 365 NS | 31 maja 2026 | N-PORT |
| FDIS · FIDELITY COVINGTON TRUST | 0,10% | 15 550 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,10% | 1 606 NS | 31 maja 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,10% | 5 421 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,09% | 111 249 NS | 30 kwietnia 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,09% | 470 701 SH | 8 sierpnia 2026 | Dziennie |
| SCHA · SCHWAB STRATEGIC TRUST | 0,09% | 165 865 NS | 31 maja 2026 | N-PORT |
| ESML · iShares Trust | 0,07% | 16 803 SH | 8 sierpnia 2026 | Dziennie |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 2 779 NS | 30 kwietnia 2026 | N-PORT |
| ISCB · iShares Trust | 0,06% | 1 479 SH | 8 sierpnia 2026 | Dziennie |